Medical Research and Clinical Trials

Breakthrough FXI Inhibition: Vortosiran Demonstrates Remarkable Efficacy and Safety in Chronic Coronary Artery Disease Patients

• Medical Research and Clinical Trials

Breakthrough FXI Inhibition: Vortosiran Demonstrates Remarkable Efficacy and Safety in Chronic Coronary Artery Disease Patients

Nana July 24, 2026

Suzhou, China & Shanghai, China – In a significant advancement for the treatment of thromboembolic diseases, Suzhou...

Read More Read more about Breakthrough FXI Inhibition: Vortosiran Demonstrates Remarkable Efficacy and Safety in Chronic Coronary Artery Disease Patients

Paradigm Shift in Cancer Therapy: Scientists Uncover Novel Mechanism for Killing BRCA-Mutant Cells

• Medical Research and Clinical Trials

Paradigm Shift in Cancer Therapy: Scientists Uncover Novel Mechanism for Killing BRCA-Mutant Cells

Raul Delapena Setiawan July 24, 2026

WORCESTER, MA – In a groundbreaking discovery poised to redefine strategies for combating some of the most...

Read More Read more about Paradigm Shift in Cancer Therapy: Scientists Uncover Novel Mechanism for Killing BRCA-Mutant Cells

Arrowhead Pharmaceuticals’ Plozasiran Achieves Landmark Success in Severe Hypertriglyceridaemia Trials, Paving the Way for Novel Treatment

• Medical Research and Clinical Trials

Arrowhead Pharmaceuticals’ Plozasiran Achieves Landmark Success in Severe Hypertriglyceridaemia Trials, Paving the Way for Novel Treatment

Nana Muazin July 24, 2026

San Francisco, CA – July 23, 2026 – Arrowhead Pharmaceuticals has announced groundbreaking top-line results from its...

Read More Read more about Arrowhead Pharmaceuticals’ Plozasiran Achieves Landmark Success in Severe Hypertriglyceridaemia Trials, Paving the Way for Novel Treatment

Breakthrough Immunotherapy Harnesses IgE Antibodies to Combat Treatment-Resistant Cancers

• Medical Research and Clinical Trials

Breakthrough Immunotherapy Harnesses IgE Antibodies to Combat Treatment-Resistant Cancers

Nila Kartika Wati July 23, 2026

London, UK – In a significant stride towards revolutionizing cancer treatment, scientists at King’s College London have...

Read More Read more about Breakthrough Immunotherapy Harnesses IgE Antibodies to Combat Treatment-Resistant Cancers

Eli Lilly’s Retatrutide Achieves Major Milestones in Type 2 Diabetes and Obesity Trials, Paving the Way for Potential Market Dominance

• Medical Research and Clinical Trials

Eli Lilly’s Retatrutide Achieves Major Milestones in Type 2 Diabetes and Obesity Trials, Paving the Way for Potential Market Dominance

Rifan Muazin July 23, 2026

Indianapolis, IN – [Date] – Eli Lilly and Company is poised to further solidify its commanding presence...

Read More Read more about Eli Lilly’s Retatrutide Achieves Major Milestones in Type 2 Diabetes and Obesity Trials, Paving the Way for Potential Market Dominance

Breakthrough in Glioblastoma Treatment: USC Researchers Uncover Potent Combination Therapy Offering New Hope

• Medical Research and Clinical Trials

Breakthrough in Glioblastoma Treatment: USC Researchers Uncover Potent Combination Therapy Offering New Hope

Laily UPN July 23, 2026

LOS ANGELES, CA – In a significant stride against one of the most aggressive and challenging cancers,...

Read More Read more about Breakthrough in Glioblastoma Treatment: USC Researchers Uncover Potent Combination Therapy Offering New Hope

Landmark Trial Unveils Breakthrough in Preventing Breast Cancer Recurrence

• Medical Research and Clinical Trials

Landmark Trial Unveils Breakthrough in Preventing Breast Cancer Recurrence

Lina Irawan July 23, 2026

PHILADELPHIA, PA – A groundbreaking, federally funded clinical trial has heralded a new era in breast cancer...

Read More Read more about Landmark Trial Unveils Breakthrough in Preventing Breast Cancer Recurrence

Devonian Health Group Secures Health Canada Approval for Pivotal Paediatric Atopic Dermatitis Trial of Thykamine

• Medical Research and Clinical Trials

Devonian Health Group Secures Health Canada Approval for Pivotal Paediatric Atopic Dermatitis Trial of Thykamine

Lina Hope July 23, 2026

Toronto, ON – [Insert Date] – Devonian Health Group Inc. (TSXV: GEV) today announced a significant advancement...

Read More Read more about Devonian Health Group Secures Health Canada Approval for Pivotal Paediatric Atopic Dermatitis Trial of Thykamine

Groundbreaking Discovery Unveils Early Driver of Aggressive Brain Cancer, Offering Hope for New Diagnostics and Treatments

• Medical Research and Clinical Trials

Groundbreaking Discovery Unveils Early Driver of Aggressive Brain Cancer, Offering Hope for New Diagnostics and Treatments

Ammar Sabilarrohman July 23, 2026

London, UK & Stanford, USA – September 8, 202X – In a significant scientific breakthrough that promises...

Read More Read more about Groundbreaking Discovery Unveils Early Driver of Aggressive Brain Cancer, Offering Hope for New Diagnostics and Treatments

Innate Pharma Achieves Key Milestone in IPH4502 Clinical Trial, Showing Promising Early Results in Advanced Cancers

• Medical Research and Clinical Trials

Innate Pharma Achieves Key Milestone in IPH4502 Clinical Trial, Showing Promising Early Results in Advanced Cancers

Asep Darmawan July 23, 2026

Innate Pharma’s innovative antibody-drug conjugate (ADC), IPH4502, targeting Nectin-4 expressing tumors, has successfully completed patient enrollment in...

Read More Read more about Innate Pharma Achieves Key Milestone in IPH4502 Clinical Trial, Showing Promising Early Results in Advanced Cancers